Glass and plastic manufacturer Bormioli Rocco Pharma is set to strengthen its pharmaceutical glass packaging services in North America with the introduction of new packaging for parenteral drugs.
The company is now offering its Delta moulded Type I glass vials and a complete portfolio of glass and plastic containers to the market.
Go deeper with GlobalData
Bormioli Rocco Pharma Americas regional sales manager Stéphane Bis said: “As a validated international supplier of premium-quality glass and plastic pharmaceutical packaging, we are excited to introduce our solutions to North American customers with designated sales support.
“We bring to the table long-term expertise in injectable pharmaceuticals packaging, as well as a complete range of integrated products matched by flexible, high-attention service.”
The company has also received US FDA approval to supply glass and plastic packaging for the pharmaceutical, biopharmaceutical and contract manufacturing organisations.
Bormioli Rocco Pharma’s Delta high-tech moulded glass vials for pharmaceutical injectables are available in various sizes and capacities.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe Delta packaging products provide higher hydrolytic resistance and internal surface homogeneity to the sensitive pharmaceuticals against delamination.
Bormioli Rocco Pharma caters to pharmaceutical and biopharmaceutical market with integrated glass and plastic containers, closures and accessories for packaging using new materials and technologies.
They include transparent and amber bottles in Type I, II, and III glass for a range of dosage forms, in addition to child-proof and tamper-evident closures.
Image: Bormioli Rocco Pharma is now making its Delta moulded Type I glass vials, and complete line of glass and plastic containers and closures, available in North America. Photo: courtesy of Bormioli Rocco.
